News tagged with methadone
Long-term methadone treatment can affect the brain
Methadone has been used to treat heroin addicts for nearly 50 years. Yet we have surprisingly incomplete knowledge about possible harmful effects from prolonged use. New research from the Norwegian Institute of Public Health ...
Medicine & Health / Medical research
Mar 23, 2011 |
5 / 5 (1) |
0
Effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine
Medicine & Health / HIV & AIDS
Mar 01, 2011 |
not rated yet |
0
Buprenorphine treatment produces improved outcome for babies born addicted
Babies born into the world addicted to drugs because of their mother's dependence on pain medication, or opioids, may be weaned off the substance more comfortably, with a shorter hospital stay and at a reduced cost, if the ...
Dec 09, 2010 |
not rated yet |
0
Year-long opiate substitution for drug misusers has 85 percent chance of cutting deaths
Giving people opiate substitution treatment to help with their drug addiction can lead to a 85% plus chance of reducing mortality, according to a new study published in the British Medical Journal today.
Oct 27, 2010 |
not rated yet |
0
Longer-lasting options to treat drug addiction
(AP) -- New treatments for addiction to heroin or narcotic painkillers promise longer-lasting relief that may remove some day-to-day uncertainty of care: A once-a-month shot is now approved and a six-month implant is in ...
Medicine & Health / Medical research
Oct 18, 2010 |
not rated yet |
0
Study confirms that methadone works and saves lives for injecting drug users
Research carried out by the universities of Bristol, Cambridge and Edinburgh found that opiate substitution treatment reduced the frequency of drug use and led to a drop in the risk of death by 13 per cent ...
Medicine & Health / Medical research
Jul 08, 2010 |
not rated yet |
1
British heroin substitute may be associated with wide-ranging sight problems
Children born to mothers prescribed the heroin substitute methadone during pregnancy may be at risk of wide-ranging sight problems, indicates a small study published ahead of print in the British Journal of Ophthalmology.
Apr 21, 2010 |
not rated yet |
0
Researchers identify potential patient safety risks among methadone maintenance treatment patients
Boston Medical Center (BMC) researchers have identified potential safety risks among methadone maintenance treatment (MMT) patients due to the quantity and accuracy of medical record documentation. Improved communication ...
Jul 08, 2009 |
not rated yet |
0
Cocaine and heroin harm placenta
Cocaine and heroin increase permeability of the placenta. Researchers writing in BioMed Central's open access journal Reproductive Biology and Endocrinology have shown that exposure to the drugs causes an increase in the ...
Jun 11, 2009 |
not rated yet |
0
Methadone
Methadone (also known as Symoron, Dolophine, Amidone, Methadose, Physeptone, Heptadon, Phy and many other names) is a synthetic opioid, used medically as an analgesic and a maintenance anti-addictive for use in patients with opioid dependency. It was developed in Germany in 1937. Although chemically unlike morphine or heroin, methadone acts on the same opioid receptors as these drugs, and thus has many of the same effects. Methadone is also used in managing severe chronic pain, owing to its long duration of action, extremely powerful effects, and very low cost. Methadone was introduced into the United States in 1947 by Eli Lilly and Company.
Methadone is useful in the treatment of opioid dependence. It has cross-tolerance with other opioids including heroin and morphine, offering very similar effects and a long duration of effect. Oral doses of methadone can stabilise patients by mitigating opioid withdrawal syndrome. Higher doses of methadone can block the euphoric effects of heroin, morphine, and similar drugs. As a result, properly dosed methadone patients can reduce or stop altogether their use of these substances.
Methadone is approved for different indications in different countries. Common is approval as an analgesic and approval for the treatment of opioid dependence. It is not intended to reduce the use of non-narcotic drugs such as methamphetamine, or alcohol.
A number of pharmaceutical companies produce and distribute methadone. The racemic hydrochloride is the only form available in most countries, such as the Netherlands, Belgium, France and in the United States, as of March 2008. The tartrate and other salts of the laevorotary form (levomethadone, with trade names including Polamidone and Heptadon) are available in Europe and elsewhere. These are more potent opioid agonists compared to racemic methadone because the dextrorotary form (d-methadone) is not an opioid agonist (it is an NMDA antagonist), therefore by using only the laevorotary form instead of the racemate the opioid agonist potency is doubled. Covidien (formerly Mallinckrodt), is the major racemic methadone producer and sells bulk methadone to producers of generic preparations and distributes its own product in the form of tablets, dispersible tablets and oral concentrate under the brand name Methadose in the United States.
For more information about Methadone, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.